-
AT&T, Justice Department await decision that could determine future of media
-
Express Scripts Reduces Employers' Annual Prescription Drug Spending Growth Rate to Historic Low in 2017
-
U.S. Workers' Compensation Prescription Drug Spending Decreased 7.6% in 2016 Through Cost-Savings Solutions, Improved Care for Injured Workers
-
High Drug Prices Frustrate Government-Sponsored Health Programs, According to New Express Scripts Drug Trend Insights
-
Express Scripts Launches Inflammatory Conditions Care Value Program(SM), Making America's Costliest Medication Class More Affordable
-
Express Scripts Launches Inflammatory Conditions Care Value Program(SM), Making America's Costliest Medication Class More Affordable
-
Express Scripts (ESRX) Announces Launch of New Diabetes Care Value Program
-
Express Scripts Launches Diabetes Care Value Programâ„ , Guaranteeing More Affordable, Higher-Quality Diabetes Care
-
Express Scripts Launches Diabetes Care Value Programâ„ , Guaranteeing More Affordable, Higher-Quality Diabetes Care
-
U.S. Workers' Compensation Prescription Drug Spending Increased 2.2 Percent in 2015
-
Express Scripts says U.S. drug spending rose 5.2 percent in 2015
-
Increase in U.S. Drug Spending Slowed to 5.2 Percent in 2015 Through Cost-Saving Solutions, Specialized Care
-
CVS says 2015 drug spending grew 5 percent, far less than in 2014
-
Express Scripts (ESRX) Aims to Clamp Down on High Drug Prices; Excludes Valeant's (VRX) Glumetza from Formulary
-
Valeant says can contain hit to dermatology, projects 2016 growth
-
Express Scripts (ESRX), Imprimis Pharma (IMMY) to Partner on Low-Cost Alternative to Turing's Daraprim
-
Express Scripts Champions $1 per Pill Access to an Alternative for Daraprim
-
Specialty pharmacies in spotlight as Valeant ties questioned